Cargando…
Cardiovascular medication in patients with raised NT-proBNP, but no heart failure in the SHEAF registry
OBJECTIVES: We aim to assess the association of cardiovascular medications with outcomes of patients referred to the diagnostic heart failure (HF) clinic with symptoms or signs of possible HF, raised N-terminal pro-brain-type natriuretic peptide (NT-proBNP) but no evidence of HF on transthoracic ech...
Autores principales: | Wolodimeroff, Elena, Garg, Pankaj, Swift, Andrew J, Fent, Graham, Lewis, Nigel, Rogers, Dominic, Charalampopoulos, Athanasios, Al-Mohammad, Abdallah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161074/ https://www.ncbi.nlm.nih.gov/pubmed/35649572 http://dx.doi.org/10.1136/openhrt-2022-001974 |
Ejemplares similares
-
Characterisation of the patients with suspected heart failure: experience from the SHEAF registry
por: Garg, Pankaj, et al.
Publicado: (2021) -
Prognosis and NT-proBNP in heart failure patients with preserved versus reduced ejection fraction
por: Salah, Khibar, et al.
Publicado: (2019) -
Clinical predictors of all‐cause mortality in patients presenting to specialist heart failure clinic with raised NT‐proBNP and no heart failure
por: Garg, Pankaj, et al.
Publicado: (2020) -
Troponin and BNP are markers for subsequent non-ischaemic congestive heart failure: the Caerphilly Prospective Study (CaPS)
por: Patterson, Christopher C, et al.
Publicado: (2018) -
Diagnostic accuracy of handheld cardiac ultrasound device for assessment of left ventricular structure and function: systematic review and meta-analysis
por: Jenkins, Sam, et al.
Publicado: (2021)